These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25702926)

  • 21. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.
    Li Q; Sullivan NR; McAllister CE; Van de Kar LD; Muma NA
    Psychoneuroendocrinology; 2013 Jul; 38(7):1145-57. PubMed ID: 23219224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal fluoxetine exposure induces life-long serotonin 5-HT₃ receptor-dependent cortical abnormalities and anxiety-like behaviour.
    Smit-Rigter LA; Noorlander CW; von Oerthel L; Chameau P; Smidt MP; van Hooft JA
    Neuropharmacology; 2012 Feb; 62(2):865-70. PubMed ID: 21964434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
    Pilar-Cuéllar F; Vidal R; Pazos A
    Br J Pharmacol; 2012 Feb; 165(4b):1046-57. PubMed ID: 21627639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2004 Aug; 497(3):285-92. PubMed ID: 15336946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells.
    Waters CM; Connell MC; Pyne S; Pyne NJ
    Cell Signal; 2005 Feb; 17(2):263-77. PubMed ID: 15494217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
    Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
    Synapse; 2001 Jul; 41(1):49-57. PubMed ID: 11354013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR
    J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents.
    Emmanouil DE; Papadopoulou-Daifoti Z; Hagihara PT; Quock DG; Quock RM
    Pharmacol Biochem Behav; 2006 Jun; 84(2):313-20. PubMed ID: 16828854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission.
    Kobayashi K; Ikeda Y; Haneda E; Suzuki H
    J Neurosci; 2008 Jun; 28(24):6272-80. PubMed ID: 18550770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration.
    Rainer Q; Nguyen HT; Quesseveur G; Gardier AM; David DJ; Guiard BP
    Mol Pharmacol; 2012 Feb; 81(2):106-12. PubMed ID: 22031471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
    Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats.
    Miyazato M; Kaiho Y; Kamo I; Kitta T; Chancellor MB; Sugaya K; Arai Y; de Groat WC; Yoshimura N
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1024-31. PubMed ID: 19640898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of 5-HT
    Colmenares-Aguilar M; Lima L
    Adv Exp Med Biol; 2017; 975 Pt 2():1129-1140. PubMed ID: 28849528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of 5-HT
    Wattiez AS; Dupuis A; Privat AM; Chalus M; Chapuy E; Aissouni Y; Eschalier A; Courteix C
    Neuropharmacology; 2017 Oct; 125():308-318. PubMed ID: 28780039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.
    Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice.
    Malagié I; David DJ; Jolliet P; Hen R; Bourin M; Gardier AM
    Eur J Pharmacol; 2002 May; 443(1-3):99-104. PubMed ID: 12044798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.